IACTA Pharmaceuticals is targeting two therapeutic areas in ophthalmology — dry eye and ocular pain — where significant unmet need exists.

The global eye care market is growing in size, however major pharmaceutical companies are reducing their internal R&D efforts, leaving a big gap in the development pipeline.

IACTA’s specific expertise is needed in this niche therapeutic area to develop the cutting-edge ocular products that patients are looking for.